No Data
No Data
H.C. Wainwright Maintains Atara Biotherapeutics(ATRA.US) With Hold Rating
H.C. Wainwright analyst Robert Burns maintains $Atara Biotherapeutics(ATRA.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 24.0% and a total average return of -22
Express News | Adiumentum Capital Fund I LP Reports 6.7% Stake in Atara Biotherapeutics as of May 15- SEC Filing
Express News | Adiumentum Capital Fund I LP: To Engage in Talks With Atara Biotherapeutics to Discuss Business, Financial Condition, Strategic Plans, Governance
Express News | Adiumentum Capital Fund I LP Says Acquired Beneficial Ownership of Atara Biotherapeutics Common Stock Shares in Belief Stock Was Undervalued
This Insider Has Just Sold Shares In Atara Biotherapeutics
We note that the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) President, Pascal Touchon, recently sold US$50k worth of stock for US$0.62 per share. It might not be a huge sale, but it did reduce their
HC Wainwright & Co. Reiterates Neutral on Atara Biotherapeutics
HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.
No Data